IONS
Ionis Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$12.36B
P/E Ratio
—
EPS
$-2.01
Beta
0.40
52W High
$86.74
52W Low
$31.66
50-Day MA
$75.46
200-Day MA
$69.53
Dividend Yield
—
Profit Margin
-30.90%
Forward P/E
90.91
PEG Ratio
25.70
About Ionis Pharmaceuticals Inc
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapies in the United States. The company is headquartered in Carlsbad, California.
Fundamentals
| Revenue (TTM) | $1.06B |
| Gross Profit (TTM) | $115.73M |
| EBITDA | $-338.65M |
| Operating Margin | -47.70% |
| Return on Equity | -67.60% |
| Return on Assets | -7.03% |
| Revenue/Share (TTM) | $6.55 |
| Book Value | $2.98 |
| Price-to-Book | 25.14 |
| Price-to-Sales (TTM) | 11.68 |
| EV/Revenue | 11.79 |
| EV/EBITDA | 135.77 |
| Quarterly Earnings Growth (YoY) | -43.70% |
| Quarterly Revenue Growth (YoY) | 87.00% |
| Shares Outstanding | $165.26M |
| Float | $163.98M |
| % Insiders | 0.66% |
| % Institutions | 106.04% |
Historical Volatility
HV 10-Day
25.68%
HV 20-Day
23.91%
HV 30-Day
27.73%
HV 60-Day
31.32%
HV Rank
15.5%
Volatility is currently contracting
Analyst Ratings
Consensus ($98.61 target)
6
Strong Buy10
Buy6
HoldData last updated: 5/1/2026